Endometrial cancer and hormone replacement therapy: Appropriate use of progestins to oppose endogenous and exogenous estrogen

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 2, 1997, Pages 399-412

  Sulak, P J ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORETHISTERONE ACETATE; PROGESTERONE;

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0030979323     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70255-3     Document Type: Article

References (41)

1. H.O. Adami U.B. Krusemo L. Bergkvist On the age-dependent associations between cancer of the breast and of the endometrium: A nationwide cohort study Br J Cancer 47 1987 77
2. D.F. Archer J.H. Pickar F. Bottiglioni The Menopause Study Group Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate Obstet Gynecol 83 1994 686
3. G. Ben-Baruch D.S. Seidman E. Schiff Outpatient endometrial sampling with the Pipelle curette Gynecol Obstet Invest 37 1994 260
4. J.V. Bokhman Two pathogenic types of endometrial carcinoma Gynecol Oncol 15 1983 10
5. L. Brinton R. Hoover Estrogen replacement therapy and endometrial cancer risk: Unresolved issues Obstet Gynecol 81 1993 265 271
6. C. Castelo-Branco E. Casals C. Sanllehy Postmenopausal hormone replacement therapy with low dose medroxyprogesterone acetate J Reprod Med 40 1995 305
7. R.C. Cherkis S.F. Patten J.C. Dickenson Significance of atypical endometrial cells detected by cervical cytology Obstet Gynecol 69 1987 786
8. P.J. DiSaia W.T. Creasman Adenocarcinoma of the uterus Clinical Gynecologic Oncology ed 4 1993 Mosby Year Book St. Louis
9. B. Ettinger Calcium regulation and bone metabolism: Basic clinical aspects Proceedings of the 9th International Conference on Calcium Regulating Hormones and Bone Metabolism, Nice, France, October 25 to November 1, 1986 1987 Excerpta Medica New York 918
10. B. Ettinger J. Selby J.J. Citron Cyclic hormone replacement therapy using quarterly progestin Obstet Gynecol 83 1994 693
11. B. Fisher J.P. Costantino C.K. Redmond Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 J Natl Cancer Inst 86 1994 527
12. R. Gambrell Jr F. Massey T. Castaneda Use of the progestogen challenge test to reduce the risk of endometrial cancer Obstet Gynecol 55 1980 732 738
13. M.M. Gelfand A. Ferenczy A prospective 1-year study of estrogen and progestin in postmenopausal women: Effects on the endometrium Obstet Gynecol 74 1989 398
14. W.E. Gibbons D.L. Moyer R.A. Lobo Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women Am J Obstet Gynecol 154 1986 456
15. R. Goldchmit Z. Katz I. Blickstein The accuracy of endometrial Pipelle sampling with and without sonographic measurement of endometrial thickness Obstet Gynecol 82 1993 727
16. D. Grady T. Bebretsadik K. Kerlikowske Hormone replacement therapy and endometrial cancer risk: A meta-analysis Obstet Gynecol 85 1995 304
17. S.B. Gusberg Tamoxifen for breast cancer: Associated endometrial cancer Cancer 65 1990 1463
18. C. Hammond F. Jelovsek K. Lee Effects of long-term estrogen replacement therapy. II. Neoplasia Am J Obstet Gynecol 133 1979 537 547
19. S. Jick A. Walker H. Jick Estrogens, progesterone, and endometrial cancer Epidemiology 4 1993 20 24
20. B. Karlsson S. Granberg M. Wikland Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study Am J Obstet Gynecol 172 1995 1488
21. D. Levine B.B. Gosink L.A. Johnson Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy Radiology 197 1995 603
22. G.H. Lipscomb S.M. Lopatine T.G. Stovall A randomized comparison of the Pipelle, Accurette, and Explora endometrial sampling devices Am J Obstet Gynecol 170 1994 591
23. J.H. Malfetano Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients Gynecol Oncol 39 1990 82
24. L.E. Nachtigall R.H. Nachtigall R.D. Nachtigall Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems Obstet Gynecol 54 1979 74 79
25. S. Nakamura T. Douchi T. Oki Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding Obstet Gynecol 87 1996 722
26. R. Osmers M. Volksen A. Schauer Vaginosonography for early detection of endometrial carcinoma? Lancet 335 1990 1569
27. M.L. Padwick J. Pryse-Davies M.I. Whitehead A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens N Engl J Med 315 1986 930
28. S.L. Parker T. Tong S. Bolden Cancer statistics, 1996 CA Cancer J Clin 46 1996 5
29. I. Persson H.O. Adami L. Bergkvist Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study BMJ 298 1989 147 151
30. L.D. Rarick M.M. Shangold S.W. Ahmed Cervical mucus and serum estradiol as predictors of response to progestin challenge Fertil Steril 54 1990 353
31. D.C. Smith R. Prentice D.J. Thompson Association of exogenous estrogen and endometrial carcinoma N Engl J Med 293 1975 1164
32. P.J. Sulak The perimenopause: A critical time in a woman's life Int J Fertil 41 1996 85
33. H.F. Taitel M.E. Kafrissen Norethindrone—a review of therapeutic applications Int J Fertil 40 1995 207
34. P. Valenzuela R.M. Sabatel V. Valls Progestin challenge test in postmenopausal patients Int J Gynecol Obstet 43 1993 313
35. L. Voigt N. Weiss J. Chu Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer Lancet 338 1991 274 277
36. M.I. Whitehead P.T. Townsend J. Pryse-Davies Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium N Engl J Med 305 1981 1599
37. D.B. Williams B.J. Voigt Y.S. Fu Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement Obstet Gynecol 84 1994 787
38. J.D. Woodruff J.H. Pickar The Menopause Study Group Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone Am J Obstet Gynecol 170 1994 1213
39. Writing Group for the PEPI Trial Effects of hormone replacement therapy on endometrial histology in postmenopausal women JAMA 257 1996 370
40. H.K. Ziel W.D. Finkle Increased risk of endometrial carcinoma among users of conjugated estrogens N Engl J Med 293 1975 1167
41. C.G. Zorlu O. Cobanoglu A.Z. Isik Accuracy of Pipelle endometrial sampling in endometrial carcinoma Gynecol Obstet Invest 38 1994 272